Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

OACC

SELL

Oaktree Acquisition Corp. III Life Sciences · Financial Services · United States · $263M · Avg Vol: $398K/d

20
StockRank
Get insider-trade alerts
Q
29
V
22
M
54
P/E (TTM)
36.9x
ROE
3.7%
D/E
0.0x
Dividend %
—
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Oaktree Acquisition Corp. III Life Sciences is a Special Purpose Acquisition Company (SPAC) explicitly formed to pursue a business combination with a private company in the life sciences sector. Leveraging the expertise of its sponsor, Oaktree Capital Management, the company seeks to identify and acquire a high-potential target within the biotechnology, pharmaceutical, or medical technology industries.

FINANCIAL SUMMARY (USD)

Year20242025TTM
Revenue—0—
EPS—0.300.29
Shares24.6M24.6M19.8M
Debt11.8K11.8K11.8K
Equity187.5M194.8M—
Op CF—-0.4M-0.5M
Inv CF—0.5M—
Fin CF—0—
Loading 1Y...
PRICE (1Y)+0.8%
10.6510.6710.7010.7210.75Jun 18Jul 13Jul 31
SMA 50SMA 200
Close
$10.74
RSI (14)
72.7
52W High
$10.88
From 52W High
1.0%

SCORE BREAKDOWN

Quality
29
ROIC
-0.6%9.7
ROE
3.7%25.0
GP/Assets
—N/A
Op. Margin
0.0%15.1
FCF/Assets
—N/A
Piotroski
215.5
Int. Cover
—N/A
D/E Ratio
0.00x89.0
Current Ratio
0.87x24.9
Value
22
P/E (TTM)
36.9x10.2
EV/EBITDA
—N/A
P/FCF
—N/A
P/B
-36.4x25.0
P/S
—N/A
Div Yield
—N/A
Momentum
54
52W High %
99%96.7
RS 6M
-7%39.1
SMA 50/200
1.00x36.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-16%17.4

FUNDAMENTALS

Market Cap
$263M
P/E (Forward)
—
Gross Margin
—

SECTOR PEERS

Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of OACC are excluded.

TickerCompanyMkt CapStockRankSignal
OACCOaktree Acquisition Corp. III Life Sciences(you)$263M20SELL
CEPOCantor Equity Partners I, Inc.$272M19STRONG SELL
DYNCDynamix Corporation$239M21SELL
BACCBlue Acquisition Corp.$292M20STRONG SELL
MACIMelar Acquisition Corp. I$236M19STRONG SELL
CUBLionheart Holdings$283M18STRONG SELL
TVAIThayer Ventures Acquisition Corporation II$282M23SELL
AACBArtius II Acquisition Inc.$290M18STRONG SELL
DMAADrugs Made In America Acquisition Corp.$260M25SELL
ATIIArchimedes Tech SPAC Partners II Co.$316M21SELL

Peer medians: ROE 9.5% · P/E 13.9x · Gross margin 100.0%

Oaktree Acquisition Corp. III Life Sciences (OACC): Stock Score Summary

Oaktree Acquisition Corp. III Life Sciences (OACC) has a MoatMap StockRank of 20/100 based on Quality (29/100), Value (22/100), and Momentum (54/100) factor scores. The current signal is SELL.

Oaktree Acquisition Corp. III Life Sciences is a Special Purpose Acquisition Company (SPAC) explicitly formed to pursue a business combination with a private company in the life sciences sector. Leveraging the expertise of its sponsor, Oaktree Capital Management, the company seeks to identify and acquire a high-potential target within the biotechnology, pharmaceutical, or medical technology industries.

Key Financial Metrics

Price$10.74
Market Cap$263M
P/E (TTM)36.93
Price/Book-36.43
Return on Equity3.7%
Return on Invested Capital-0.6%
Debt/Equity0.00x
Operating Margin0.0%

Oaktree Acquisition Corp. III Life Sciences operates in the Shell Companies industry, part of the Financial Services sector (United States).

Frequently Asked Questions

What is Oaktree Acquisition Corp. III Life Sciences’s (OACC) StockRank?
MoatMap’s StockRank for Oaktree Acquisition Corp. III Life Sciences (OACC) is 20/100, with a Sell signal. It is a composite of Quality (29), Value (22), and Momentum (54) factor ranks across MoatMap’s 20,000+ stock universe.
Does Oaktree Acquisition Corp. III Life Sciences have an economic moat?
Oaktree Acquisition Corp. III Life Sciences (OACC) has a Quality factor score of 29/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Oaktree Acquisition Corp. III Life Sciences a buy, hold, or sell?
MoatMap’s current signal for Oaktree Acquisition Corp. III Life Sciences (OACC) is Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Oaktree Acquisition Corp. III Life Sciences in?
Oaktree Acquisition Corp. III Life Sciences (OACC) operates in the Financial Services sector, specifically the Shell Companies industry (United States).
Browse all ranked stocksOACC deep dive reportAI ChampionsHow we score stocksSense-check another stock